Growth expansion Recent facility expansion and ISO 7 cleanrooms in Austria indicate increased production capacity and regional presence, presenting cross-selling opportunities for additional single-use bioprocess and cold chain solutions to new site operations and nearby CDMOs.

Next gen tech Launch of RoSS.BLST and next-generation blast freezer highlights a focus on high-value biologics process efficiency and control. This creates upsell potential for customers seeking advanced single-use containers, compliant secondary packaging, and temperature-controlled logistics solutions.

Leadership momentum New appointments including Chief Commercial Officer and Board Chair signal strategic growth and customer-focused go-to-market strengthening, suggesting readiness for enterprise deals, channel partnerships, and long-cycle sales opportunities.

Collaborative alliances Partnership with BioPhorum Operations Group demonstrates a commitment to industry collaboration, opening doors for joint programs, broader adoption of single-use technologies, and opportunities with peer networks and consortium-funded projects.

Diverse customer reach Serving biopharma manufacturers, CDMOs, CGT process needs, vaccine manufacturing transfers, and bulk drug substance handling implies cross-sell potential across bioprocess containers, freeze-thaw platforms, transport and ultra-cold storage solutions to multiple pharma segments.